FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000907464> ?p ?o ?g. }

• W2000907464 endingPage "536" @default.
• W2000907464 startingPage "536" @default.
• W2000907464 abstract "Letters16 March 1999Primaquine Prophylaxis against MalariaD. Gray Heppner Jr., MD, Robert A. Gasser Jr., MD, and Kent E. Kester, MDD. Gray Heppner Jr., MDWalter Reed Army Institute of Research; Washington, DC 20307 (Heppner)Walter Reed Army Institute of Research; Washington, DC 20307 (Gasser)Walter Reed Army Institute of Research; Washington, DC 20307 (Kester)Search for more papers by this author, Robert A. Gasser Jr., MDWalter Reed Army Institute of Research; Washington, DC 20307 (Heppner)Walter Reed Army Institute of Research; Washington, DC 20307 (Gasser)Walter Reed Army Institute of Research; Washington, DC 20307 (Kester)Search for more papers by this author, and Kent E. Kester, MDWalter Reed Army Institute of Research; Washington, DC 20307 (Heppner)Walter Reed Army Institute of Research; Washington, DC 20307 (Gasser)Walter Reed Army Institute of Research; Washington, DC 20307 (Kester)Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-130-6-199903160-00009 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail TO THE EDITOR:Malaria prophylaxis for travelers should be safe and should protect against Plasmodium falciparum and P. vivax, the two most prevalent species. In this light, we discuss Soto and colleagues' report of primaquine prophylaxis against malaria (1).First, the importance of excluding G6PD deficiency before primaquine prophylaxis cannot be overstated. G6PD deficiency, originally described as “primaquine sensitivity,” is characterized by hemolysis that is clinically apparent 6 to 72 hours after exposure to oxidant drugs such as primaquine. African-American persons are commonly G6PD deficient, as demonstrated by Hockwald and colleagues (2), who administered primaquine, 30 mg/d, for 14 days ...References1. Soto J, Toledo J, Rodriquez M, Sanchez J, Herrera R, Padilla J, et al . Primaquine prophylaxis against malaria in nonimmune Colombian soldiers: efficacy and toxicity. A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 1998;129:241-4. LinkGoogle Scholar2. Hockwald RS, Arnold J, Clayman CB, Alving AS. Toxicity of primaquine in Negroes. JAMA. 1952;149:1568-70. CrossrefMedlineGoogle Scholar3. Fryauff DJ, Baird JK, Basri H, Sumawinata I, Purnomo , Richie TL, et al . Randomised placebo-controlled trial of primaquine for prophylaxis of falciparum and vivax malaria. Lancet. 1995;346:1190-3. CrossrefMedlineGoogle Scholar4. Ohrt C, Richie TL, Widjaja H, Shanks GD, Fitriadi J, Fryauff DJ, et al . Mefloquine compared with doxycycline for the prophylaxis of malaria in Indonesian soldiers. A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 1997;126:963-72. LinkGoogle Scholar5. Nosten F, ter Kuile F, Maelankiri L, Chongsuphajaisiddhi T, Nopdonrattakoon L, Tangitchot S, et al . Mefloquine prophylaxis prevents malaria during pregnancy: a double blind, placebo-controlled study. J Infect Dis. 1994;169:595-603. CrossrefMedlineGoogle Scholar Author, Article, and Disclosure InformationAffiliations: Walter Reed Army Institute of Research; Washington, DC 20307 (Heppner)Walter Reed Army Institute of Research; Washington, DC 20307 (Gasser)Walter Reed Army Institute of Research; Washington, DC 20307 (Kester) PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoPrimaquine Prophylaxis against Malaria in Nonimmune Colombian Soldiers: Efficacy and Toxicity: A Randomized, Double-Blind, Placebo-Controlled Trial Jaime Soto , Julia Toledo , Maria Rodriquez , Jorge Sanchez , Ricardo Herrera , Julio Padilla , and Jonathan Berman Primaquine Prophylaxis against Malaria Michele Barry Primaquine Prophylaxis against Malaria Jaime Soto and Jonathan Berman Metrics Cited byAntimalarial AgentsDrugs for malaria 16 March 1999Volume 130, Issue 6Page: 536KeywordsDoxycyclineHemoglobinMalariaMefloquineMultidrug resistancePlasmodium falciparumPregnancyPrimaquineProphylaxisProspective studies ePublished: 15 August 2000 Issue Published: 16 March 1999 Copyright & PermissionsCopyright © 1999 by American College of Physicians. All Rights Reserved.PDF downloadLoading ..." @default.
• W2000907464 created "2016-06-24" @default.
• W2000907464 creator A5023513706 @default.
• W2000907464 creator A5073739899 @default.
• W2000907464 creator A5080329476 @default.
• W2000907464 date "1999-03-16" @default.
• W2000907464 modified "2023-09-24" @default.
• W2000907464 title "Primaquine Prophylaxis against Malaria" @default.
• W2000907464 cites W2014682737 @default.
• W2000907464 cites W2018320053 @default.
• W2000907464 cites W2045628422 @default.
• W2000907464 cites W2102664616 @default.
• W2000907464 cites W2166068761 @default.
• W2000907464 doi "https://doi.org/10.7326/0003-4819-130-6-199903160-00009" @default.
• W2000907464 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10075625" @default.
• W2000907464 hasPublicationYear "1999" @default.
• W2000907464 type Work @default.
• W2000907464 sameAs 2000907464 @default.
• W2000907464 citedByCount "4" @default.
• W2000907464 crossrefType "journal-article" @default.
• W2000907464 hasAuthorship W2000907464A5023513706 @default.
• W2000907464 hasAuthorship W2000907464A5073739899 @default.
• W2000907464 hasAuthorship W2000907464A5080329476 @default.
• W2000907464 hasConcept C203014093 @default.
• W2000907464 hasConcept C2776793103 @default.
• W2000907464 hasConcept C2777425658 @default.
• W2000907464 hasConcept C2778048844 @default.
• W2000907464 hasConcept C2778371730 @default.
• W2000907464 hasConcept C2779997623 @default.
• W2000907464 hasConcept C71924100 @default.
• W2000907464 hasConceptScore W2000907464C203014093 @default.
• W2000907464 hasConceptScore W2000907464C2776793103 @default.
• W2000907464 hasConceptScore W2000907464C2777425658 @default.
• W2000907464 hasConceptScore W2000907464C2778048844 @default.
• W2000907464 hasConceptScore W2000907464C2778371730 @default.
• W2000907464 hasConceptScore W2000907464C2779997623 @default.
• W2000907464 hasConceptScore W2000907464C71924100 @default.
• W2000907464 hasIssue "6" @default.
• W2000907464 hasLocation W20009074641 @default.
• W2000907464 hasLocation W20009074642 @default.
• W2000907464 hasOpenAccess W2000907464 @default.
• W2000907464 hasPrimaryLocation W20009074641 @default.
• W2000907464 hasRelatedWork W1484561267 @default.
• W2000907464 hasRelatedWork W2145726869 @default.
• W2000907464 hasRelatedWork W2357740749 @default.
• W2000907464 hasRelatedWork W2366412098 @default.
• W2000907464 hasRelatedWork W2416508209 @default.
• W2000907464 hasRelatedWork W2652205004 @default.
• W2000907464 hasRelatedWork W2765363790 @default.
• W2000907464 hasRelatedWork W3018160686 @default.
• W2000907464 hasRelatedWork W4213421799 @default.
• W2000907464 hasRelatedWork W4323341933 @default.
• W2000907464 hasVolume "130" @default.
• W2000907464 isParatext "false" @default.
• W2000907464 isRetracted "false" @default.
• W2000907464 magId "2000907464" @default.
• W2000907464 workType "article" @default.